Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 21, 2010


The Automation Partnership has appointed Phillip Sefton as commercial director.

Sefton most recently served as vice president of commercial operations at Qiagen, where he was responsible for sales and market development in Europe, Asia, Australia, Africa, and Latin America.

Prior to Qiagen, Phillip spent eight years with Boehringer Mannheim (now part of Roche Diagnostics), where he worked in the company's Biochemical Business Unit and Laboratory Diagnostics Business Division. He also worked as a researcher at Beecham Pharmaceuticals (now GlaxoSmithKline).

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.